AI ScreeningAI ChatPricing
  1. US-listed companies
  2. NEUROCRINE BIOSCIENCES INC
  3. Financials
  4. Free cash flow

NEUROCRINE BIOSCIENCES INC【NBIX】

Market cap
$12.9B
P/E ratio
SummaryFinancials
Period EndFree cash flow (Million USD)YoY (%)
Dec 31, 2024557+54.09%
Dec 31, 2023362+11.99%
Dec 31, 2022323+38.52%
Dec 31, 2021233+7.12%
Dec 31, 2020218+58.48%
Dec 31, 2019137+79.36%
Dec 31, 201877-175.59%
Dec 31, 2017-101-8.18%
Dec 31, 2016-110+176.20%
Dec 31, 2015-40-18.09%
Dec 31, 2014-49+61.69%
Dec 31, 2013-30-16.86%
Dec 31, 2012-36+2434.24%
Dec 31, 2011-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)